To hear about similar clinical trials, please enter your email below

Trial Title: Performance of Whole Body MRI in Extraplevic Disease Detection in Patients Undergoing Pelvic Exenteration for Gynecological Maligniancies

NCT ID: NCT05816005

Condition: Gynecologic Cancer

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Summary: The aim of this prospective observational diagnostic study is to investigate the diagnostic accuracy od extrapelvic disease detection using Whole-body-MRI (WB-MRI) in patients with gynecologic cancer candidate to the pelvic exenteration.

Criteria for eligibility:

Study pop:
Patients with pelvic maligniancies that will undergo to preoperative contrast enhanced MRI to precisely define the extent of local and/or distant disease before pelvic exenteration

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Age > 18 years - Written Informed Consent - All patients with recurrent gynecological cancer that are planned to undergo pelvic exenteration or laterally extended pelvic resection, both with curative and palliative intent - Patients considered fit for srugery Exclusion Criteria: - Controindication to MRI (Claustrophobia, implanted ferromagnetic materials or foreign objects, Known intolerance or controindication to the MRI contrast agent, cardiac pacemaker) - Individuals who are not able or willing to tolerate the required prologed stationary supine position during examination (approximately 40-60 minutes) - Patient unable to give informed consent

Gender: Female

Gender based: Yes

Gender description: Only women can be included

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Fondazione Policlinico Universitaro "A. Gemelli" IRCCS

Address:
City: Roma
Zip: 00168
Country: Italy

Status: Recruiting

Contact:
Last name: Giacomo G Avesani, MD

Phone: 0630156054

Phone ext: +39
Email: giacomo.avesani@policlinicogemelli.it

Start date: July 1, 2021

Completion date: June 2024

Lead sponsor:
Agency: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class: Other

Source: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05816005

Login to your account

Did you forget your password?